Search by Drug Name or NDC

    NDC 50268-0331-12 Flucytosine 250 mg/1 Details

    Flucytosine 250 mg/1

    Flucytosine is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvPAK. The primary component is FLUCYTOSINE.

    Product Information

    NDC 50268-0331
    Product ID 50268-331_0e88b79b-c69b-3c90-e063-6394a90a294f
    Associated GPIs 11000020000105
    GCN Sequence Number 009542
    GCN Sequence Number Description flucytosine CAPSULE 250 MG ORAL
    HIC3 W3B
    HIC3 Description ANTIFUNGAL AGENTS
    GCN 42560
    HICL Sequence Number 004131
    HICL Sequence Number Description FLUCYTOSINE
    Brand/Generic Generic
    Proprietary Name Flucytosine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Flucytosine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name FLUCYTOSINE
    Labeler Name AvPAK
    Pharmaceutical Class Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA204652
    Listing Certified Through 2025-12-31

    Package

    NDC 50268-0331-12 (50268033112)

    NDC Package Code 50268-331-12
    Billing NDC 50268033112
    Package 20 BLISTER PACK in 1 BOX (50268-331-12) / 1 CAPSULE in 1 BLISTER PACK (50268-331-11)
    Marketing Start Date 2021-04-12
    NDC Exclude Flag N
    Pricing Information N/A